Beneficial immunomodulatory activity of Lactobacillus casei in malnourished mice pneumonia: effect on inflammation and coagulation.
- 2006-07
- Nutrition 22(7-8)
- Graciela Agüero
- J. Villena
- S. Racedo
- C. Haro
- S. Alvarez
- PubMed: 16815495
- DOI: 10.1016/J.NUT.2006.03.013
Abstract
Objective: The effect of Lactobacillus casei CRL 431 immunomodulatory activity on inflammation and coagulation during pneumococcal pneumonia was investigated in malnourished mice.
Methods: Weaned mice were malnourished after they consumed a protein-free diet for 21 d. Malnourished mice were treated for 7 d with a balanced conventional diet (BCD) with L. casei supplementation (BCD+Lc) or without it. The malnourished control group received only a protein-free diet whereas well-nourished control (WNC) mice consumed BCD ad libitum. Mice were challenged by the intranasal route with pneumococci at the end of each dietary treatment. Lung injury, leukocyte recruitment, cytokine production, coagulation tests, and fibrin(ogen) deposition in lungs were evaluated.
Results: Malnourished control mice showed impaired leukocyte recruitment and cytokine production, and more severe lung injuries when compared with WNC mice. Coagulation tests were significantly impaired in malnourished control group versus WNC group. Repletion with BCD or BCD+Lc improved these parameters, but only BCD+Lc mice achieved the values of WNC mice. In addition, the interleukin-10 level was higher in the BCD+Lc group than in the WNC group.
Conclusion: Repletion with supplemental L. casei accelerated recovery of the defense mechanisms against pneumococci by inducing different cytokine profiles. These cytokines would be involved in the improvement of the immune response and in the induction of a more efficient regulation of the inflammatory process, limiting the injury caused by infection.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Lacticaseibacillus casei | Elevated Interleukin-10 Levels | Beneficial | Moderate |
Lacticaseibacillus casei | Improved Coagulation Parameters | Beneficial | Moderate |
Lacticaseibacillus casei | Reduced Lung Injury | Beneficial | Large |
Lacticaseibacillus casei R0215 | Elevated Interleukin-10 Levels | Beneficial | Moderate |
Lacticaseibacillus casei R0215 | Enhanced Leukocyte Recruitment | Beneficial | Moderate |
Lacticaseibacillus casei R0215 | Improved Coagulation Parameters | Beneficial | Moderate |
Lacticaseibacillus casei R0215 | Improved Cytokine Production | Beneficial | Large |
Lacticaseibacillus casei R0215 | Improved Immune Response | Beneficial | Large |
Lacticaseibacillus casei R0215 | Reduced Severity of Lung Injuries | Beneficial | Large |
Lactobacillus casei | Enhanced Anti-inflammatory Response | Beneficial | Moderate |
Lactobacillus casei | Improved Coagulation Parameters | Beneficial | Moderate |
Lactobacillus casei | Improved Cytokine Production | Beneficial | Large |
Lactobacillus casei | Improved Immune Response | Beneficial | Large |
Lactobacillus casei | Reduced Lung Injury | Beneficial | Large |
Lactobacillus casei HA-108 | Elevated Interleukin-10 Levels | Beneficial | Moderate |
Lactobacillus casei HA-108 | Improved Coagulation Parameters | Beneficial | Moderate |
Lactobacillus casei HA-108 | Improved Immune Response | Beneficial | Large |
Lactobacillus casei HA-108 | Reduced Lung Injury | Beneficial | Large |
Lactobacillus casei HA-108 | Regulated Inflammation | Beneficial | Large |
Lactobacillus casei Lc-11 | Enhanced Anti-inflammatory Response | Beneficial | Moderate |
Lactobacillus casei Lc-11 | Improved Coagulation Parameters | Beneficial | Moderate |
Lactobacillus casei Lc-11 | Improved Immune Response | Beneficial | Large |
Lactobacillus casei Lc-11 | Reduced Lung Injury | Beneficial | Large |
Lactobacillus casei LC03 | Enhanced Leukocyte Recruitment | Beneficial | Moderate |
Lactobacillus casei LC03 | Improved Coagulation Parameters | Beneficial | Moderate |
Lactobacillus casei LC03 | Improved Cytokine Production | Beneficial | Large |
Lactobacillus casei LC03 | Improved Lung Injury Outcomes | Beneficial | Moderate |
Lactobacillus casei PXN 37 | Elevated Interleukin-10 Levels | Beneficial | Moderate |
Lactobacillus casei PXN 37 | Enhanced Immunity to Pneumococcal Infections | Beneficial | Large |
Lactobacillus casei PXN 37 | Improved Coagulation Parameters | Beneficial | Moderate |
Lactobacillus casei PXN 37 | Reduced Lung Injury | Beneficial | Large |
Lactobacillus casei PXN 37 | Regulated Inflammation | Beneficial | Large |
Lactobacillus casei R0215 | Improved Coagulation Test Results | Beneficial | Moderate |
Lactobacillus casei R0215 | Improved Cytokine Production | Beneficial | Large |
Lactobacillus casei R0215 | Improved Immune Response | Beneficial | Large |
Lactobacillus casei R0215 | Improved Inflammatory Regulation | Beneficial | Large |
Lactobacillus casei R0215 | Improved Leukocyte Recruitment | Beneficial | Large |
Lactobacillus casei R0215 | Improved Lung Injury Outcomes | Beneficial | Moderate |
Lactobacillus casei SD-5213 | Improved Coagulation Test Results | Beneficial | Moderate |
Lactobacillus casei SD-5213 | Increased IL-10 Levels | Beneficial | Moderate |
Lactobacillus casei SD-5213 | Reduced Lung Injury | Beneficial | Large |
Lactobacillus casei SD-5842 | Improved Coagulation Parameters | Beneficial | Moderate |
Lactobacillus casei SD-5842 | Improved Cytokine Production | Beneficial | Large |
Lactobacillus casei SD-5842 | Improved Immune Response | Beneficial | Large |
Lactobacillus casei SD-5842 | Reduced Lung Injury | Beneficial | Large |
Lactobacillus casei SD5213 | Improved Cytokine Production | Beneficial | Large |
Lactobacillus casei SD5213 | Improved Leukocyte Recruitment | Beneficial | Large |
Lactobacillus casei SD5213 | Regulated Inflammatory Process | Beneficial | Moderate |
Lactobacillus casei subsp. casei | Elevated Interleukin-10 Levels | Beneficial | Moderate |
Lactobacillus casei subsp. casei | Improved Coagulation Parameters | Beneficial | Moderate |
Lactobacillus casei subsp. casei | Improved Defense Mechanism Recovery | Beneficial | Large |
Lactobacillus casei subsp. casei | Reduced Severity of Lung Injuries | Beneficial | Large |
Lactobacillus casei UALc-03 | Improved Coagulation Parameters | Beneficial | Moderate |
Lactobacillus casei UALc-03 | Improved Cytokine Production | Beneficial | Large |
Lactobacillus casei UALc-03 | Improved Leukocyte Recruitment | Beneficial | Large |
Lactobacillus casei UALc-03 | Reduced Lung Injury | Beneficial | Large |
Lactobacillus casei VK4 | Enhanced Leukocyte Recruitment | Beneficial | Moderate |
Lactobacillus casei VK4 | Improved Coagulation Parameters | Beneficial | Moderate |
Lactobacillus casei VK4 | Improved Immune Response | Beneficial | Large |
Lactobacillus casei VK4 | Reduced Inflammation Levels | Beneficial | Moderate |
Lactobacillus casei VK4 | Reduced Lung Injury | Beneficial | Large |
Lactobacillus paracasei 431 | Improved Coagulation Parameters | Beneficial | Moderate |
Lactobacillus paracasei 431 | Improved Cytokine Production | Beneficial | Large |
Lactobacillus paracasei 431 | Improved Defense Mechanism Recovery | Beneficial | Large |
Lactobacillus paracasei 431 | Improved Leukocyte Recruitment | Beneficial | Large |
Lactobacillus paracasei 431 | Reduced Lung Injury | Beneficial | Large |
Lactobacillus paracasei 431 | Regulated Inflammatory Process | Beneficial | Moderate |